Hyperphosphatemia Therapeutics Market to Hit Sales of $3.53 Billion by 2028 | Over 93% Physicians Prefer Binders For Treating Hyperphosphatemia
02 nov. 2022 08h55 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Hyperphosphatemia is a condition characterized by elevated levels of phosphate in the blood. Phosphate plays an important role in cell function...